In conclusion, this study confirmed the role of EMP1 in RSL3-induced ferroptosis and gefitinib resistance in HNSCC and preliminarily explored the underlying mechanism during the regulation process. The gene discussed is EMP1; the disease is head and neck squamous cell carcinoma.